Comments are due June 6.
News
Latest
The legal principles discussed also apply to individuals with other types of substance use disorders.
AHA’s national advisor for cybersecurity and risk speaks with leaders from University of Vermont Medical Center about the attack.
CMS plans to launch next week the online portal through which uninsured and self-pay patients may initiate the dispute resolution process.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.
Medicare and Medicaid will cover a second Pfizer or Moderna COVID-19 booster at no cost to eligible enrollees.
President Biden yesterday directed the HHS secretary to coordinate the federal response.
HHS has stopped distributing the monoclonal antibody sotrovimab because the BA.2 omicron variant now predominates in every U.S. state and territory.
The Food and Drug Administration yesterday alerted health care providers to a recall and change in reprocessing methods for certain urological endoscopes made by Karl Storz.
AHA has a new toolkit that hospitals and health systems can use in their communities to encourage vaccinations against influenza and COVID-19.
The proposed rule would enable more families to access health insurance subsidies through the Health Insurance Marketplace.
The House Energy and Commerce Subcommittee on Health today held a hearing on legislation to reauthorize federal mental health programs and support mental health and wellbeing.
The provision being challenged by AHA and AMA implicates the arbitration process for determining fair payment for services by out-of-network providers.
The agency expects MA plans to see an average revenue increase of 8.5% under the final policies.
Hospitals and health systems, and their community and public health partners, are invited to share how they are overcoming challenges to make a positive difference during the COVID-19 pandemic.
Beginning today through the end of the public health emergency, the free tests are available through eligible health care providers and pharmacies.
Participants in the Healthy Start Initiative may apply for up to $180,000 each in supplemental funding.
Three more regions are no longer authorized to treat patients at high risk for progressing to severe COVID-19 with sotrovimab because the monoclonal antibody is unlikely to work against the BA.2 variant predominating there.
The 2022 AHA Annual Membership Meeting is just three weeks away, and I’m looking forward to seeing many of you April 24-26 in Washington, D.C.